
Danish medical technology company Ambu's top management declines to comment the big stock purchase made by CEO Juan Jose Gonzales upon request from domestic business daily Børsen. Last week, Gonzales bought shares worth USD 4.1m (DKK 26m) in the medtech firm.
Investors do, however, point to an aggressive communication style, highlighting what they see as positive elements.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app